Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-116001·Avalon Ventures XI, L.P.
Schedule 13D ownership disclosure
Janux Therapeutics Inc
Security class unavailable · CUSIP: 47103J105
Event date: 2024-11-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 925,088
- Percent of class
- 1.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-116001
- Form type
- SC 13D/A
- Filer
- Avalon Ventures XI, L.P.
- CIK
- CIK 1652901
- Filed
- Nov 08, 2024
- Reporting period
- Nov 06, 2024
- Description
- Schedule 13D beneficial ownership